These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. MAPKAP kinase 2-deficiency prevents neurons from cell death by reducing neuroinflammation--relevance in a mouse model of Parkinson's disease. Thomas T; Timmer M; Cesnulevicius K; Hitti E; Kotlyarov A; Gaestel M J Neurochem; 2008 Jun; 105(5):2039-52. PubMed ID: 18298661 [TBL] [Abstract][Full Text] [Related]
5. One-hit stochastic decline in a mechanochemical model of cytoskeleton-induced neuron death I: cell-fate arrival times. Lomasko T; Clarke G; Lumsden CJ J Theor Biol; 2007 Nov; 249(1):1-17. PubMed ID: 17697688 [TBL] [Abstract][Full Text] [Related]
6. Scale-free neurodegeneration: cellular heterogeneity and the stretched exponential kinetics of cell death. Clarke G; Lumsden CJ J Theor Biol; 2005 Apr; 233(4):515-25. PubMed ID: 15748912 [TBL] [Abstract][Full Text] [Related]
7. Double-strand RNA dependent protein kinase (PKR) is involved in the extrastriatal degeneration in Parkinson's disease and Huntington's disease. Bando Y; Onuki R; Katayama T; Manabe T; Kudo T; Taira K; Tohyama M Neurochem Int; 2005 Jan; 46(1):11-8. PubMed ID: 15567511 [TBL] [Abstract][Full Text] [Related]
8. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea. Huot P; Lévesque M; Parent A Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832 [TBL] [Abstract][Full Text] [Related]
9. [Mechanisms of neuronal death in Huntington's disease. Second part: therapeutic challenges]. Bantubungi K; Blum D Rev Med Brux; 2007; 28(6):487-94. PubMed ID: 18265808 [TBL] [Abstract][Full Text] [Related]
11. 'Tissue' transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease. Mastroberardino PG; Iannicola C; Nardacci R; Bernassola F; De Laurenzi V; Melino G; Moreno S; Pavone F; Oliverio S; Fesus L; Piacentini M Cell Death Differ; 2002 Sep; 9(9):873-80. PubMed ID: 12181738 [TBL] [Abstract][Full Text] [Related]
12. The differential susceptibility of specific neuronal populations: insights from Huntington's disease. Mitchell IJ; Griffiths MR IUBMB Life; 2003 Jun; 55(6):293-8. PubMed ID: 12938730 [TBL] [Abstract][Full Text] [Related]
13. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208 [TBL] [Abstract][Full Text] [Related]
14. Diminished hippocalcin expression in Huntington's disease brain does not account for increased striatal neuron vulnerability as assessed in primary neurons. Rudinskiy N; Kaneko YA; Beesen AA; Gokce O; Régulier E; Déglon N; Luthi-Carter R J Neurochem; 2009 Oct; 111(2):460-72. PubMed ID: 19686238 [TBL] [Abstract][Full Text] [Related]
15. Photoreceptor death: spatiotemporal patterns arising from one-hit death kinetics and a diffusible cell death factor. Burns J; Clarke G; Lumsden CJ Bull Math Biol; 2002 Nov; 64(6):1117-45. PubMed ID: 12508534 [TBL] [Abstract][Full Text] [Related]
16. Implication of PTEN in production of reactive oxygen species and neuronal death in in vitro models of stroke and Parkinson's disease. Zhu Y; Hoell P; Ahlemeyer B; Sure U; Bertalanffy H; Krieglstein J Neurochem Int; 2007 Feb; 50(3):507-16. PubMed ID: 17169462 [TBL] [Abstract][Full Text] [Related]
17. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Novikova L; Garris BL; Garris DR; Lau YS Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572 [TBL] [Abstract][Full Text] [Related]
18. Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration. Morale MC; Serra PA; L'episcopo F; Tirolo C; Caniglia S; Testa N; Gennuso F; Giaquinta G; Rocchitta G; Desole MS; Miele E; Marchetti B Neuroscience; 2006; 138(3):869-78. PubMed ID: 16337092 [TBL] [Abstract][Full Text] [Related]
19. Oxidative stress and neurotoxicity. Sayre LM; Perry G; Smith MA Chem Res Toxicol; 2008 Jan; 21(1):172-88. PubMed ID: 18052107 [TBL] [Abstract][Full Text] [Related]
20. One-hit stochastic decline in a mechanochemical model of cytoskeleton-induced neuron death II: transition state metastability. Lomasko T; Clarke G; Lumsden CJ J Theor Biol; 2007 Nov; 249(1):18-28. PubMed ID: 17727892 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]